New hep C testing/treatment campaign’s successes
The Eliminate Hepatitis C Australia Partnership (EC Australia) was created in 2018 to bring together researchers, scientists, government, health services and community organisations to work toward eliminating hepatitis C as a public health threat in Australia by 2030 (see last issue for more).
Continue reading “It’s Your Right in SA”
Competing priorities for people who inject drugs
Opioid substitution treatment (OST) clinics are considered ideal locations for providing treatment for people with chronic hepatitis C virus infection who inject drugs, a vital priority group for achieving the goal of HCV elimination. But despite the availability of highly effective treatments with relatively few side effects, treatment uptake is yet to reach the level needed to achieve elimination.
Continue reading ““I’ll have hep C treatment eventually.””
The prevalence of hepatitis C and hepatitis B in Australian prisons is higher than in in the wider community, but prison settings also present and opportunity for testing, monitoring and treatment, especially for hepatitis C since the introduction of new, highly effective drugs that has shortened treatment time dramatically.
Up to 40 per cent of prisoners have hepatitis C, compared to only one per cent in the wider community, and three to four per cent of prisoners have hepatitis B, compared to just under one per cent in the wider South Australian community.
Continue reading “Tackling Hepatitis and Other Blood-borne Viruses in Prisons”
One of the key planks of Australia’s hepatitis C elimination strategy is increasing treatment through management by General Practitioners (GPs), making it easier for individuals to receive treatment and facilitating access to hard-to-reach communities.
GP training programs have been rolled out across the country and GP prescribing had increased from 8 per cent in March to 31 per cent in December. However, most prescribing (62 per cent) are still by specialists and GP prescriptions in South Australia, Northern Territory, ACT and Victoria are significantly below average.
Continue reading “Handy Tool Simplifies Management of Hepatitis C Treatment”
The need for support and information about hepatitis C brought together a small band of people in Adelaide some 20 years ago. That small group from the 90s grew to become today’s Hepatitis SA.
Providing support to people dealing with chronic hepatitis remains at the heart Hepatitis SA’s services. The close mutual support of the early days has developed into formal, on-going support groups, telephone support and face to face information sessions.
Continue reading “Need for Hepatitis Support Continues”
The development of direct-acting antiviral (DAA) treatments has revolutionised the treatment of hepatitis C in Australia. DAAs are effective and, when patients follow the medication regime, can cure more than 90% of those who take the treatment. But at the moment there are limited resources to inform and guide health professionals as they try to provide adherence support to those undergoing DAA treatment.
Medication adherence refers to the way an individual takes a medication, including the use of the correct medication, the correct dose and time, duration and timely refilling of repeat prescriptions.
Continue reading “Helping People Adhere to Treatment Helps Treatment Succeed”